The role of quantitative PCR for the immune monitoring of cancer patients
- PMID: 12079490
- DOI: 10.1517/14712598.2.5.557
The role of quantitative PCR for the immune monitoring of cancer patients
Abstract
Human tumour immunology is at a standstill whereas implemented cancer vaccines have shown effectiveness in inducing immune responses detectable in circulating lymphocytes. In most circumstances, however, such immune responses are not sufficient to induce cancer regression. This paradoxical observation could be explained in several ways depending upon the immunological endpoint used for immune monitoring. For instance, analysis of immune responses in circulating lymphocytes that address the presence of T cells bearing T-cell receptors specific for the epitope used for vaccination, can accurately enumerate the number of T cells elicited by the vaccines but does not yield information about their functional status. Other monitoring strategies may yield general information about the reactivity of various T cells in response to a relevant stimulus and, therefore, may provide information more relevant to the purpose of the immunisation. Furthermore, the material used to monitor immune responses may, in itself, determine the significance of the findings obtained. In the assessment of the therapeutic efficacy of specific cancer treatment, analysis of immune responses in circulating lymphocytes (systemic response) may not be as relevant as the analysis of the same effector populations within the tumour microenvironment (peripheral response). This review will describe a novel approach that allows extreme flexibility in the analysis of systemic and peripheral responses by accurately measuring the level of expression of relevant genes using quantitative real-time reverse transcriptase polymerase chain reaction.
Similar articles
-
T-cell-directed cancer vaccines: the melanoma model.Expert Opin Biol Ther. 2001 Mar;1(2):277-90. doi: 10.1517/14712598.1.2.277. Expert Opin Biol Ther. 2001. PMID: 11727535 Review.
-
A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.Clin Immunol. 2006 Feb-Mar;118(2-3):188-94. doi: 10.1016/j.clim.2005.10.002. Epub 2005 Dec 20. Clin Immunol. 2006. PMID: 16368270
-
[Immune monitoring and cancer vaccine].Nihon Rinsho. 2012 Dec;70(12):2183-8. Nihon Rinsho. 2012. PMID: 23259394 Review. Japanese.
-
Systems-Level Immune Monitoring by Mass Cytometry.Methods Mol Biol. 2019;1913:33-48. doi: 10.1007/978-1-4939-8979-9_3. Methods Mol Biol. 2019. PMID: 30666597
-
Melanoma vaccines: the paradox of T cell activation without clinical response.Cancer Chemother Pharmacol. 2000;46 Suppl:S62-6. doi: 10.1007/pl00014052. Cancer Chemother Pharmacol. 2000. PMID: 10950150 Review.
Cited by
-
Detection of circulating tumor lysate-reactive CD4+ T cells in melanoma patients.Cancer Immunol Immunother. 2004 Jun;53(6):560-6. doi: 10.1007/s00262-004-0502-3. Epub 2004 Feb 25. Cancer Immunol Immunother. 2004. PMID: 14985861 Free PMC article.
-
Potency analysis of cellular therapies: the emerging role of molecular assays.J Transl Med. 2007 May 30;5:24. doi: 10.1186/1479-5876-5-24. J Transl Med. 2007. PMID: 17537259 Free PMC article. Review.
-
Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR).J Transl Med. 2003 Dec 15;1(1):12. doi: 10.1186/1479-5876-1-12. J Transl Med. 2003. PMID: 14675481 Free PMC article.
-
Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy.J Transl Med. 2004 Apr 22;2(1):13. doi: 10.1186/1479-5876-2-13. J Transl Med. 2004. PMID: 15104791 Free PMC article.
-
Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals.Cancer Immunol Immunother. 2007 Jul;56(7):1047-63. doi: 10.1007/s00262-006-0246-3. Epub 2006 Nov 24. Cancer Immunol Immunother. 2007. PMID: 17124584 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources